Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,314.40
(
0.75%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
100.62
(
-0.03%
)
Bitcoin
73,907.49
(
-0.05%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 95086

Sunday, 05/02/2010 5:10:16 PM

Sunday, May 02, 2010 5:10:16 PM

Post# of 257253
1Q10 sales of BMY’s top-selling drugs: 
 
             Sales (M$)  YoY Chg 
 Plavix        1700*      16% 
 Abilify        617*       5% 
 Reyataz        373       16% 
 Sustiva        335       15% 
 Avapro         314        4% 
 Baraclude      216       42% 
 Orencia        169       36% 
 Erbitux        166*       1% 
 Sprycel        131       49% 
 Ixempra         29       21% 
 Onglyza         10*      n/a 
  
 *Subject to co-marketing agreement; 
 BMY books a portion of worldwide sales.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Unleash the power of Level 2

Spot liquidity moves with access to US order books.

Sign Up